Autolus Therapeutics's total assets for Q4 2024 were $782.73M, a decrease of -5.41% from the previous quarter. AUTL total liabilities were $355.40M for the fiscal quarter, a 1.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.